APLM
Price
$18.12Alerts
Change
-$0.57 (-3.05%)
Updated
Nov 11 closing price
Capitalization
56.26M
Intraday BUY SELL Signals
IPHA
Price
$1.59Alerts
Change
+$0.07 (+4.61%)
Updated
Nov 11 closing price
Capitalization
160.85M
134 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APLM vs IPHA

APLM vs IPHA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APLM vs. IPHA commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLM is a Hold and IPHA is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for APLM with price predictions
Nov 11, 2026

APLM in -16.20% downward trend, declining for three consecutive days on November 05, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where APLM declined for three days, in 223 of 249 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on APLM as a result. In 74 of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

The Moving Average Convergence Divergence Histogram (MACD) for APLM turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 26 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.

The 10-day moving average for APLM crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for APLM entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where APLM's RSI Indicator exited the oversold zone, 18 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where APLM advanced for three days, in 140 of 176 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

APLM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. APLM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 48 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.704) is normal, around the industry mean (3.498). P/E Ratio (-1.287) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (3.761) is also within normal values, averaging (440.869).

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APLM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for IPHA with price predictions
Nov 10, 2026

IPHA's RSI Indicator recovers from oversold territory

The RSI Indicator for IPHA moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 21 of the 25 cases the stock moved higher. This puts the odds of a move higher at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 61 of 78 cases where IPHA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on IPHA as a result. In 92 of 113 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

The Moving Average Convergence Divergence (MACD) for IPHA just turned positive on October 20, 2026. Looking at past instances where IPHA's MACD turned positive, the stock continued to rise in 35 of 50 cases over the following month. The odds of a continued upward trend are 70%.

Following a +5.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where IPHA advanced for three days, in 148 of 199 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

IPHA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 50-day moving average for IPHA moved below the 200-day moving average on November 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPHA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

The Aroon Indicator for IPHA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-3.971) is normal, around the industry mean (3.498). P/E Ratio (-2.824) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (55.556) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. IPHA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
IPHA: Fundamental Ratings
IPHA
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
25
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLMIPHA
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
54%
Bullish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 2 days ago
79%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (APLM: $18.69 vs. IPHA: $1.52)
Brand notoriety: APLM and IPHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLM: 115% vs. IPHA: 7%
Market capitalization -- APLM: $56.26M vs. IPHA: $160.85M
APLM [@Biotechnology] is valued at $56.26M. IPHA’s [@Biotechnology] market capitalization is $160.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLM’s FA Score shows that 0 FA rating(s) are green while IPHA’s FA Score has 2 green FA rating(s).

  • APLM’s FA Score: 0 green, 5 red.
  • IPHA’s FA Score: 2 green, 3 red.
According to our system of comparison, IPHA is a better buy in the long-term than APLM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLM’s TA Score shows that 4 TA indicator(s) are bullish while IPHA’s TA Score has 6 bullish TA indicator(s).

  • APLM’s TA Score: 4 bullish, 6 bearish.
  • IPHA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IPHA is a better buy in the short-term than APLM.

Price Growth

APLM (@Biotechnology) experienced а -10.66% price change this week, while IPHA (@Biotechnology) price change was +14.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.

Reported Earning Dates

IPHA is expected to report earnings on Mar 25, 2027.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

APLM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLM has been loosely correlated with SNTI. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APLM jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLM
1D Price
Change %
APLM100%
-3.05%
SNTI - APLM
47%
Loosely correlated
+11.81%
HCWB - APLM
45%
Loosely correlated
-6.75%
PRAX - APLM
39%
Loosely correlated
+2.55%
MGX - APLM
37%
Loosely correlated
+8.04%
IPHA - APLM
36%
Loosely correlated
+4.61%
More

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
+1.33%
MDGL - IPHA
43%
Loosely correlated
-0.04%
APLM - IPHA
36%
Loosely correlated
+2.41%
ATYR - IPHA
35%
Loosely correlated
-0.26%
CCXI - IPHA
34%
Loosely correlated
N/A
FENC - IPHA
34%
Loosely correlated
-2.31%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CONY14.430.44
+3.15%
YieldMax COIN Option Income Strategy ETF (CONY)
QXQ30.780.71
+2.35%
SGI Enhanced Nasdaq 100 ETF (QXQ)
SSS21.650.32
+1.48%
CYBER HORNET S&P 500 and Solana 75/25 Strategy ETF (SSS)
DFII12.540.12
+0.98%
Ft Vest Bitcoin Strategy & Target Income ETF
PCY20.480.02
+0.10%
Invesco Emerging Markets Sovereign Debt ETF (PCY)